SHOCK Flashcards

1
Q

is a life-threatening condition that occurs when the
body is not getting enough blood flow.
➢ Affects all body systems

A

SHOCK

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

The cell swells and the cell membrane becomes more
permeable, and fluids and electrolytes seep from and
into the cell. Mitochondria and lysosomes are
damaged, and the cell dies

A

Cellular Effects of Shock

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Compensatory stage of shock

A

Blood pressure norm
Vasoconsriction
HR normal
Fight or flight respone
Skin cold and clammy
Decrease ADH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

In the progressive stage of shock, the mechanisms
that regulate blood pressure can no longer
compensate and the MAP falls below normal limits,
with an average systolic blood pressure of less than
90 mm Hg.

A

PROGRESSIVE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

The irreversible (or refractory) stage of shock
represents the point along the shock continuum at
which organ damage is so severe that the patient
does not respond to treatmen

A

IRREVERSIBLE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

can occur as a progression
along the shock continuum or as a syndrome unto
itself

A

Multiple organ dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Overall Management Strategies in Shock

FVN

A

Fluid replacement
Vasoactive medications
Nutritional support

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

to restore
vasomotor tone and improve cardiac function

A

Vasoactive medications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

to address the
metabolic requirements that are often
dramatically increased in shock

A

Nutritional support

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

are administered in all forms
of shock to improve the patient’s hemodynamic
stability when fluid therapy alone cannot maintain
adequate MAP.

A

VASOACTIVE MEDICATION THERAPY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

occurs when there is a reduction
in intravascular volume of 15% to 25%. This would
represent a loss of 750 to 1,300 mL of blood in a
70-kg (154-lb) person.

A

Hypovolemic shock

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

MEDICAL MANAGEMENT
Hypovolemic shock

A

restore intravascular volume to reverse the sequence
of events leading to inadequate tissue perfusion
2. redistribute fluid volume
3. correct the underlying cause of the fluid loss as
quickly as possible

Proper positioning (modified Trendelenburg)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What to remember for hpovol shock for crystalloid solution?

A

Remember the 3:1 rule for crystalloid solutions: For
every 1 mL of approximate blood loss, 3 mL of crystalloid
solution is given

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

occurs when the heart’s ability to
contract and to pump blood is impaired and the
supply of oxygen is inadequate for the heart and
tissues

A

CARDIOGENIC SHOCK

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

The causes of cardiogenic shock are known
as either

A

coronary or non-coronary.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

seen most often in
patients with
myocardial infarction

occurs when a
significant amount of
the left ventricular
myocardium has been
destroyed

A

CORONARY

17
Q

causes can be related to
metabolic problems and tension
pneumothorax

A

NON-CORONARY

18
Q

INITIATION OF FIRST-LINE TREATMENT
First-line treatment of cardiogenic shock involves the following
actions:

A

Supplying supplemental oxygen
● Controlling chest pain
● Providing selected fluid support
● Administering vasoactive medications

19
Q

Caused by a mechanical obstruction that prevents an
adequate volume of blood from filling the heart
chambers

A

OBSTRUCTIVE SHOCK

20
Q

Obstructive Shock: Management

A

Control airway
● Intubation
● Treat the underlying cause

21
Q

results from a maldistribution or mismatch of blood
flow to the cells.
➢ shock state resulting from displacement of blood
volume creating a relative hypovolemia

A

CIRCULATORY OR DISTRIBUTIVE SHOCK

22
Q

Fluid replacement must be instituted to correct the
hypovolemia

A

Crystalloids, colloids, and blood products may be
administered to increase the intravascular volume

23
Q

Classification of Circulatory shock

A
  1. Septic shock
  2. Neurogenic shock
  3. Anaphylactic shock
24
Q

The disorder is thought to be a response to that
release microbes or immune mediators, such as

A

tumor necrosis factor and interleukin- 1.

25
Q

occurs due to sepsis and leads to a
major decrease in tissue perfusion to organs and
tissues.

A

Septic shock

26
Q

Resuscitation goals include:

A
  • MAP more than 65 mmHg
  • Target CVP of 8-12 mmHg (12-15 mmHg if
    ventilated)
  • Central venous O2 saturation (ScvO2) equal or
    more than 70%
27
Q

results in massive
vasodilation and a decrease in peripheral vascular
resistance, causing blood to pool in the venous
system.

A

This loss of sympathetic tone

28
Q

occurs rapidly and is
life-threatening.

A

ANAPHYLACTIC SHOCK

29
Q

Medical Management
ANAPHYLACTIC SHOCK

A

Removing the causative antigen, administering
medications that restore vascular tone, and providing
emergency support of basic life functions.
● Epinephrine is given for its vasoconstrictive action.

30
Q

Any pathogenic organism can cause septic shock.
❖Gram-negative bacteria, such as E

A

Escherichia coli,
Klebsiella pneumoniae, Serratia, Enterobacter, and
Pseudomonas rank as the most common causes and
account for up to 70% of all cases

31
Q
A